Grants and Contributions:
Title:
UK Biomanufacturing - 10140683 - H5Nx Vaccine - Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles
Agreement Number:
1032265
Agreement Value:
$498,000.00
Agreement Date:
May 1, 2025 - Mar 30, 2027
Description:
“As part of the international consortium project “H5Nx Vaccine: Pan-H5Nx subtype Influenza Protection: mRNA Vaccine Using optimized Lipid Nanoparticles”, this project proposes to develop a groundbreaking biomanufacturing platform for a novel pan-H5Nx mRNA vaccine.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Calgary, Alberta, CA T2A 7H8
Reference Number:
172-2025-2026-Q2-1032265
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
717183537
Recipient Type:
For-profit organization
Recipient's Operating Name:
Northern RNA Inc.
Recipient's Legal Name:
NORTHERN RNA INC.
Federal Riding Name:
Calgary Forest Lawn
Federal Riding Number:
48006
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254